MaxCyte, Inc. (NASDAQ:MXCT) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte First Quarter Earnings Conference Call.
Maxcyte Inc. (MXCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,993,200 | $1,400,223 | +154% | 0% |
| 2. | Cadian Capital Eric Bannasch | 1,722,942 | $1,210,367 | -54% | 0.15% |
| 3. | AQR Capital Management Cliff Asness | 1,221,182 | $857,881 | +1200% | 0% |
| 4. | Luminus Management Jonathan Barrett And Paul Segal | 1,150,000 | $807,875 | +387% | 0.49% |
| 5. | Stonepine Capital Timothy P. Lynch | 1,004,673 | $705,783 | +115% | 0.28% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.29 | 50,000 | $64,500.00 | 161,811 | 2025-08-13 | Filing | |
| $1.37 | 75,000 | $102,915.00 | 175,000 | 2025-08-13 | Filing | |
| $1.37 | 100,000 | $137,220.00 | 398,328 | 2025-08-13 | Filing | |
| $1.39 | 80,000 | $111,040.00 | 230,577 | 2025-08-13 | Filing | |
| $1.29 | 50,000 | $64,500.00 | 150,879 | 2025-08-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.82 | 10,142 | $8,265.73 | 151,669 | 2026-03-17 | Filing | |
| $2.09 | 10,684 | $22,377.64 | 39,893 | 2025-06-25 | Filing | |
| $3.18 | 1,211 | $3,850.13 | 59,439 | 2025-03-18 | Filing | |
| $3.18 | 353 | $1,122.29 | 64,219 | 2025-03-18 | Filing | |
| $3.18 | 6,939 | $22,061.16 | 111,811 | 2025-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,798,473 | $6,180,926 | 0% | |
| 2. | 8,200,000 | $5,760,500 | 0.9% | |
| 3. | 5,043,356 | $3,542,958 | 3.17% | |
| 4. | 3,981,816 | $2,799,217 | 0% | |
| 5. | 3,688,131 | $2,590,912 | 0% |
News See All
Here's Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors
Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund" Q1 2026 Investor Letter. A copy of the letter can be downloaded here.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to MaxCyte, Inc.’s fourth quarter earnings conference call. At this time, all participants are in a listen-only mode.
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery
MaxCyte Inc. (NASDAQ:MXCT) is one of the best penny stocks under $1 to buy right now.
13 Best Penny Stocks Under $1 to Buy Right Now
Earlier on January 8, Royce Investment Partners co-chief investment officer Francis Gannon appeared on Yahoo Finance's 'Market Domination Overtime' to suggest that it is time for investors to get on board...
MaxCyte, Inc. (NASDAQ:MXCT) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte Third Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio
MaxCyte, Inc. (NASDAQ:MXCT) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 4, MaxCyte, Inc. (NASDAQ:MXCT) announced signing a strategic platform license with Adicet Bio, Inc.
10 Best 52-Week Low Penny Stocks to Buy Now
On March 26, Gabelli released its Small Cap Outlook for 2025 and beyond.
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte Second Quarter Earnings Conference Call. [Operator Instructions] Today's conference is being recorded.
MaxCyte, Inc. (MXCT): A Bull Case Theory
We came across a bullish thesis on MaxCyte, Inc. (MXCT) on Substack by OppCost. In this article, we will summarize the bulls’ thesis on MXCT. MaxCyte, Inc.
Hedge Fund Resource Center